|
|
|
|
"The Future of High Potency APIs" |
|
Date:
Tuesday, December 8, 2009
Time: 10:00 AM EST
(3:00 PM GMT)
Duration: 60
minutes
Format:
Presentation and Interactive Q & A
Location: Your
desktop!
Price: FREE
Space is limited - reserve your spot NOW! |
 |
|
In our continued
commitment as global provider of the most accurate,
trusted industry information available,
Chemical Information Services
is pleased to offer the first installment in our
partnership webinar series.
|

|
Becker & Associates
is world-renown for its life science chemistry
and market databases. This session will provide
participants with the
most current information on high potency
active pharmaceutical
ingredients
in the pipeline. |
View this INFORMATIVE webinar! Gain insight into the
following:
-
Origin
of the High Potency Database
-
Overview
of the High Potency Market
-
Low & very low API-dosage
in Phase l, ll and lll
-
A selection of pre-launched HPAPI
-
The future
of HPAPI
In addition to this wealth of information, attendees
will also have an opportunity to participate
in an INTERACTIVE Q & A Session led by Dr. Becker.
Becker & Associates provides advisory
services and solutions for pharmaceutical and fine
chemical industries worldwide. Comprised of R&D
production scientists and market professionals,
Becker specializes in Life Science processes and
market development. Its databases provide essential
scientific, technological, commercial and patent data
gathered to fulfill the information needs of drug
development and manufacturing professionals.
Our Speaker: |
|
|
|
 |
Abram Becker, M.Sc,
D.Sc. - Owner, Becker & Associates
With over 40 years of
chemical and pharmaceutical industry experience, Dr.
Becker is an expert on the subject of life-science
encyclopedic databases. His numerous scientific
achievements include development of about 160 production
processes as well as advancement & production of APIs
and formulations. He was involved in the isolation and
modifications of natural active ingredients (alkaloids,
peptides, steroids), semi synthesis & synthesis of APIs
(anticancer, antiviral, cardiovascular, CNS, hormones)
and other fine chemicals. He was also involved in
non-life-science chemistry: high performance / liquid
crystal monomers, flame-retardants, antioxidants &
surface-active agents. He currently holds approximately
40 patents and has published several books on various
topics within the industry.
|
|
|
Chemical Information Services
- 9101 LBJ Frwy., Suite 310 - Dallas, TX 75243 USA
Becker & Associates
- 6 rue de Parc Royal -
75003 Paris, FRANCE |